Skip to main
SNYR

SNYR Stock Forecast & Price Target

SNYR Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Synergy CHC is positioned for continued growth and success with its strong performance in expanding the FOCUSfactor brand and capitalizing on the growing brain health supplements and energy RTD markets. Despite some challenges and competitive industry, the company has shown resilience and profitability, and is expected to make significant progress and growth in the next several years. With a solid balance sheet and potential catalysts on the horizon, such as new products and international expansion, the stock is undervalued and presents a promising investment opportunity.

Bears say

Synergy CHC is facing financial difficulties, as shown by their weak Q1 results with a significant decrease in revenue and negative Pro EPS. Despite a lower price target of $3.75 due to high risks, the company has a strong potential with its new RTD products and international growth. However, risks such as balance sheet/liquidity, competition, and changing consumer trends remain as potential roadblocks for the company's success in the health and wellness industry. Additionally, the company's high debt-to-cash ratio is concerning and could impact their financial stability.

SNYR has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Synergy CHC Corp (SNYR) Forecast

Analysts have given SNYR a Strong Buy based on their latest research and market trends.

According to 2 analysts, SNYR has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Synergy CHC Corp (SNYR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.